On Tuesday, Immunocore Holdings plc ADR (NASDAQ: IMCR) was -3.91% down from the session before settling in for the closing price of $55.54. A 52-week range for IMCR has been $42.21 – $76.98.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 88.61% over the last five years. When this article was written, the company’s average yearly earnings per share was at -47.75%. With a float of $48.78 million, this company’s outstanding shares have now reached $49.73 million.
The firm has a total of 497 workers. Let’s measure their productivity.
Immunocore Holdings plc ADR (IMCR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Immunocore Holdings plc ADR stocks. The insider ownership of Immunocore Holdings plc ADR is 1.91%, while institutional ownership is 73.97%. The most recent insider transaction that took place on Apr 01 ’24, was worth 280,262. In this transaction CHIEF HR OFFICER of this company sold 4,375 shares at a rate of $64.06, taking the stock ownership to the 0 shares. Before that another transaction happened on Feb 28 ’24, when Company’s HEAD OF R&D sold 36,509 for $68.59, making the entire transaction worth $2,504,158. This insider now owns 0 shares in total.
Immunocore Holdings plc ADR (IMCR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 8.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -47.75% per share during the next fiscal year.
Immunocore Holdings plc ADR (NASDAQ: IMCR) Trading Performance Indicators
You can see what Immunocore Holdings plc ADR (IMCR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -2.37 in one year’s time.
Technical Analysis of Immunocore Holdings plc ADR (IMCR)
Analysing the last 5-days average volume posted by the [Immunocore Holdings plc ADR, IMCR], we can find that recorded value of 0.53 million was better than the volume posted last year of 0.49 million. As of the previous 9 days, the stock’s Stochastic %D was 4.08%. Additionally, its Average True Range was 2.50.
During the past 100 days, Immunocore Holdings plc ADR’s (IMCR) raw stochastic average was set at 28.17%, which indicates a significant increase from 1.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.14% in the past 14 days, which was lower than the 44.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $65.23, while its 200-day Moving Average is $59.84. Now, the first resistance to watch is $54.85. This is followed by the second major resistance level at $56.32. The third major resistance level sits at $57.15. If the price goes on to break the first support level at $52.55, it is likely to go to the next support level at $51.72. Now, if the price goes above the second support level, the third support stands at $50.25.
Immunocore Holdings plc ADR (NASDAQ: IMCR) Key Stats
There are 49,821K outstanding shares of the company, which has a market capitalization of 2.65 billion. As of now, sales total 249,430 K while income totals -55,290 K. Its latest quarter income was 70,340 K while its last quarter net income were -19,790 K.
